Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome

Basit Öğe Kaydı
dc.authorid0000-0003-2045-1709en_US
dc.authorid0000-0003-1110-6671en_US
dc.authorid0000-0003-4170-7865en_US
dc.contributor.authorTerekeci, Murat Hakan
dc.contributor.authorNalbant, Selim
dc.contributor.authorÖzgürtaş, Taner
dc.contributor.authorÇelik, Serkan
dc.contributor.authorTapan, Serkan
dc.contributor.authorSanisoğlu, Yavuz S.
dc.contributor.authorŞahan, Burak
dc.contributor.authorSayan, Özkan
dc.contributor.authorKüçükardalı, Yaşar
dc.contributor.authorTop, Cihan
dc.contributor.authorÖktenli, Çağatay
dc.date.accessioned2024-07-12T21:01:24Z
dc.date.available2024-07-12T21:01:24Z
dc.date.issued2009en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractThere is little evidence in the literature about circulating asymmetric dimethylarginine (ADMA) levels in Behçet's syndrome (BS). The aim of the present study was 1. to measure the levels of ADMA in male patients with BS, 2. to compare ADMA levels with healthy volunteers, and 3. to evaluate whether there is any difference between patients both with / without thrombosis and in active / inactive stage. In patients with BS, CRP levels were higher than controls. The mean ADMA and C-reactive protein (CRP) levels were significantly higher in active stage patients and patients with thrombosis than in patients during the inactive stage and without thrombosis. In conclusion, we did not find any significant difference in ADMA levels between patients with BS and healthy controls. Serum ADMA concentrations, however,en_US
dc.identifier.citationTerekeci, M. H., Nalbant, S., Özgürtaş, T., Çelik, S., Tapan, S., Sanisoğlu, Y. S., Şahan, B., Sayan, Ö., Küçükardalı, Y., Top, C. ve Öktenli, Ç. (2009). Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome. Aktuelle Rheumatologie, Thieme Publishing Group. 34(2), s. 121-125.en_US
dc.identifier.endpage125en_US
dc.identifier.issn0341-051X
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage121en_US
dc.identifier.urihttps://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2008-1027716
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3499
dc.identifier.volume34en_US
dc.language.isoenen_US
dc.publisherThieme Publishing Groupen_US
dc.relation.ispartofAktuelle Rheumatologieen_US
dc.relation.isversionof10.1055 / s-2008-1027716en_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY00155
dc.subjectBehçet's diseaseen_US
dc.subjectasymmetric dimethylarginineen_US
dc.subjectendothelial dysfunctionen_US
dc.subjectthrombosisen_US
dc.subjectactive stageen_US
dc.titleIncreased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndromeen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu